These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21566110)

  • 1. Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States.
    Reddy PN; Sampaio MS; Kuo HT; Martin P; Bunnapradist S
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1481-7. PubMed ID: 21566110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients.
    Yang YW; Lee CY; Hu RH; Lee PH; Tsai MK
    Clin Exp Nephrol; 2014 Feb; 18(1):144-50. PubMed ID: 23605388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Induction Type Influence Outcomes in Kidney Transplant Recipients at Different Phases of Hepatitis B Infection?
    Sureshkumar KK; Chopra B
    Exp Clin Transplant; 2019 Aug; 17(4):457-460. PubMed ID: 30066624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Brandl A; Stolzlechner P; Eschertzhuber S; Aigner F; Weiss S; Vogel W; Krannich A; Neururer S; Pratschke J; Graziadei I; Öllinger R
    Transpl Int; 2016 Apr; 29(4):471-82. PubMed ID: 26716608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database.
    Young BY; Gill J; Huang E; Takemoto SK; Anastasi B; Shah T; Bunnapradist S
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):845-52. PubMed ID: 19201918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation: A Multicenter Cohort Study in Korea.
    Lee J; Cho JH; Lee JS; Ahn DW; Kim CD; Ahn C; Jung IM; Han DJ; Lim CS; Kim YS; Kim YH; Lee JP
    Medicine (Baltimore); 2016 May; 95(21):e3671. PubMed ID: 27227927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
    Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
    Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
    Kang W; Sampaio MS; Huang E; Bunnapradist S
    Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of kidney transplantation recipients with hepatitis in the antiviral therapy era: a single-center experience.
    Lu K; Wang HP; Chen YS
    Transplant Proc; 2014; 46(2):460-3. PubMed ID: 24655988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
    Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
    Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and Kidney Allograft Survival with National Kidney Paired Donation.
    Leeser DB; Thomas AG; Shaffer AA; Veale JL; Massie AB; Cooper M; Kapur S; Turgeon N; Segev DL; Waterman AD; Flechner SM
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):228-237. PubMed ID: 31992572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
    Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
    Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.